| # | Country | Total Patents | |
|---|---|---|---|
| #1 | Japan | 7 | |
| #2 | China | 4 | |
| #3 | EPO (European Patent Office) | 4 | |
| #4 | Israel | 3 | |
| #5 | Australia | 2 | |
| #6 | Canada | 2 | |
| #7 | Republic of Korea | 2 | |
| #8 | WIPO (World Intellectual Property Organization) | 2 | |
| #9 | United States | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology | |
| #3 | Measurement | |
| #4 | Foods and drinks |
| # | Technology | |
|---|---|---|
| #1 | Therapeutic chemical compounds | |
| #2 | Medical preparations | |
| #3 | Peptides | |
| #4 | Analysing materials | |
| #5 | Enzymes | |
| #6 | Microorganisms |
| # | Name | Total Patents |
|---|---|---|
| #1 | Chen Wen Y | 19 |
| #2 | Wagner Thomas E | 3 |
| #3 | Chen Wen Yuan | 2 |
| #4 | Chen Wen Yaun | 2 |
| #5 | Payne James | 1 |
| Publication | Filing date | Title |
|---|---|---|
| WO2019169330A1 | Method for treating cancers expressing prolactin receptor | |
| AU2011328935A1 | Use of prolactin receptor antagonist and chemotherapeutic drug for treating ovarian cancer | |
| CN102341118A | Compositions and methods for visualizing and eliminating cancer stem cells | |
| US2004033948A1 | Multimeric ligands with enhanced stability |